SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors

Comprehensive genomic profiling enables the detection of genomic biomarkers in advanced solid tumors. However, efficient patient screening for the success of precision oncology remains challenging due to substantial barriers, such as genotyping costs and accessibility to matched therapies. To addres...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2021-11, Vol.112 (11), p.4425-4432
Hauptverfasser:	Nakamura, Yoshiaki, Fujisawa, Takao, Taniguchi, Hiroya, Bando, Hideaki, Okamoto, Wataru, Tsuchihara, Katsuya, Yoshino, Takayuki, Ohtsu, Atsushi
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cancer therapies Cell cycle Chemotherapy circulating tumor DNA Clinical trials Collaboration Esophagus Gene amplification Genomics Genotyping Metastasis Molecular modelling multiomics Mutation next‐generation sequencing Oncology Patients Plasma Precision medicine precision oncology real‐world data Review Sample size Solid tumors Technological change Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!